Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Harbin Gloria Pharmaceuticals Co., Ltd

Market Cap 6.02B 890M 768M 708M 663M 1.24B 84.57B 1.26B 8.36B 3.26B 41.16B 3.34B 3.27B 143B P/E Ratio 2024
24.2x
P/E Ratio 2025 18.2x
Enterprise Value 5.18B 766M 661M 610M 571M 1.07B 72.8B 1.09B 7.2B 2.81B 35.43B 2.87B 2.81B 123B EV / Sales 2024
2.12x
EV / Sales 2025 2.82x
Free-Float
88.53%
Yield 2024 *
-
Yield 2025 -
1 day+1.50%
1 week-4.26%
Current month-8.78%
1 month-15.89%
3 months-20.12%
6 months-12.90%
Current year-12.05%
1 week 2.61
Extreme 2.61
2.75
1 month 2.61
Extreme 2.61
3.2
Current year 2.61
Extreme 2.61
3.99
1 year 2.61
Extreme 2.61
4.08
3 years 1.66
Extreme 1.66
4.08
5 years 1.66
Extreme 1.66
4.08
10 years 1.66
Extreme 1.66
9.8
Manager TitleAgeSince
Chief Executive Officer 53 2022-12-25
Corporate Officer/Principal 42 2018-04-17
Corporate Officer/Principal 40 2019-05-22
Director TitleAgeSince
Director/Board Member 53 2022-11-10
Director/Board Member 40 2025-03-13
Chairman 47 2025-02-05
Date Insider Type Main position Quantity % Market Cap.
25-07-01Sell 587,500 0.0283%
25-07-01Sell

Director

259,600 0.0125%
25-07-01Sell 587,500 0.0283%
Change 5-day change 1-year change 3-year change Capi.($)
+1.50%-4.26%-9.70%+37.06% 890M
+0.75%+1.43%+7.10%+83.21% 45.63B
+1.81%-1.75%+43.70%+87.13% 33.53B
+0.44%-0.85%-7.69%+41.96% 11.81B
-0.11%+1.44%+13.31%+107.51% 11.69B
+0.59%+0.78%+36.70%+129.46% 9.12B
+2.40%+0.08%+18.35%+42.53% 7.16B
+3.10%+1.42%+46.01%-14.77% 6.49B
+1.37%+0.35%+30.18%+241.01% 6.45B
+0.51%-3.04%-43.06%-3.48% 5.16B
Average +1.21%-0.10%+13.49%+75.16% 13.79B
Weighted average by Cap. +1.07%-0.30%+18.73%+82.87%

Financials

2024 2025
Net sales 2.44B 361M 312M 287M 269M 504M 34.28B 511M 3.39B 1.32B 16.69B 1.35B 1.32B 57.78B 2.14B 316M 273M 251M 235M 441M 29.99B 447M 2.97B 1.16B 14.6B 1.18B 1.16B 50.55B
Net income 233M 34.4M 29.71M 27.38M 25.63M 48.02M 3.27B 48.77M 323M 126M 1.59B 129M 126M 5.51B 377M 55.7M 48.11M 44.33M 41.49M 77.76M 5.29B 78.97M 523M 204M 2.58B 209M 205M 8.92B
Net Debt -509M -75.17M -64.93M -59.83M -56M -105M -7.15B -107M -706M -275M -3.48B -282M -276M -12.04B -838M -124M -107M -98.57M -92.26M -173M -11.77B -176M -1.16B -454M -5.73B -465M -455M -19.84B
Logo Harbin Gloria Pharmaceuticals Co., Ltd
HARBIN GLORIA PHARMACEUTICALS Co Ltd is a China-based company principally engaged in the research, development, production and sale of pharmaceuticals. The Company operates its businesses through three segments. The Traditional Chinese Medicine segment's main product is Annao Pills and Tablets. The Chemical Pharmaceuticals segment's products include cardiovascular and cerebrovascular drugs, musculoskeletal drugs, vitamins, electrolytes, analgesics, anti-infectives, anti-tumor drugs and others. The Others segment engages in pharmaceutical research and development, clinical services and others. The Company distributes its products within the domestic market and to overseas markets.
Employees
2,350
Date Price Change Volume
26-06-12 2.700 ¥ +1.50% 49,981,360
26-06-11 2.660 ¥ -1.85% 45,162,460
26-06-10 2.710 ¥ -0.37% 36,877,670
26-06-09 2.720 ¥ +0.37% 50,249,515
26-06-08 2.710 ¥ -3.90% 51,532,166

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002437 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!